All patients (n = 213) | Lymph node involvement | p | |
---|---|---|---|
Positive (n = 60) | Negative (n = 153) | Â | |
Gender | Â | Â | 0.712 |
 Female | 9 | 20 |  |
 Male | 51 | 133 |  |
Age at surgery | 67 (51–85) | 66 (39–81) | 0.890 |
Tumor location | Â | Â | 0.338 |
 Upper | 4 | 18 |  |
 Middle | 33 | 79 |  |
 Lower | 23 | 56 |  |
Tumor size (mm) | 40 (10–95) | 35 (10–106) | 0.146 |
Tumor depth (pT) | Â | Â | < 0.0001* |
 T1 | 29 | 123 |  |
 T2 | 7 | 10 |  |
 T3 | 22 | 18 |  |
 T4a | 2 | 0 |  |
 T4b | 0 | 2 |  |
Lymph node metastasis (pN) | Â | Â | < 0.0001* |
 N0 | 0 | 152 |  |
 N1 | 45 | 0 |  |
 N2 | 12 | 1 |  |
 N3 | 3 | 0 |  |
Pathological stage | Â | Â | < 0.0001* |
 IA | 1 | 109 |  |
 IB | 0 | 23 |  |
 IIA | 0 | 18 |  |
 IIB | 27 | 0 |  |
 IIIA | 23 | 1 |  |
 IIIB | 4 | 0 |  |
 IIIC | 5 | 2 |  |
Tumor histology | Â | Â | 0.032* |
 Squamous cell carcinoma | 49 | 141 |  |
 Adenocarcinoma | 5 | 6 |  |
 Other | 6 | 6 |  |
Tumor differentiation of SCC | Â | Â | Â |
 G1 | 11 | 17 | 0.005* |
 G2 | 23 | 101 |  |
 G3 | 15 | 21 |  |
 N/A | 0 | 2 |  |
Prognosis | Â | Â | Â |
 Alive | 40 | 124 | 0.017* |
 Deceased from esophageal ca. | 10 | 7 |  |
 Deceased from other ca. | 0 | 4 |  |
 Deceased from other diseases | 10 | 18 |  |